Access the Highest Possible Sensitivity through the Simoa® Accelerator Laboratory
Discover our collaborative approach for:
- Custom biopharmaceutical research
- Custom Simoa® biomarker assays
- Clinical sample testing
- Reliable delivery of results
Are you ready to expand the possibilities of biomarker science?The Simoa® Accelerator Laboratory is a full-service center for biopharmaceutical research. The Accelerator Lab provides exploratory protein biomarker testing services for enhanced pharmacokinetics, pharmacodynamics, efficacy, safety, and target engagement. Take advantage of our expertise and full suite of instruments to access custom ultrasensitive biomarker assays, conduct robust clinical sample testing, and enjoy reliable delivery of results— through a single streamlined service.
Work with our team of experts to meet your research objectives while reducing costs and accelerating your timeline to drug approvals.
Why Choose the Simoa® Accelerator Laboratory?
In our full-service center, you can access expert advice and rapid development of ultrasensitive custom biomarker assays. You’ll also enjoy a guided selection of the best antibody pairs and other biomarker testing services through the Simoa® Accelerator Lab. Choose between commercially available reagents, custom kits, or specific components built with your own proprietary antibodies.
You can use your assay and defined protocols in-house or in the Accelerator Lab. Whatever you choose, expect tailored support from an experienced team of Quanterix scientists dedicated to sponsored research using Simoa® technologies.
The Accelerator Lab gives individualized attention to each project. They can help your organization achieve its R&D goals by leveraging:
- Longitudinal clinical sample testing
- Flexible scaling to handle up to thousands of samples
- Full QMS infrastructure for end-to-end project management
- Custom assay development from Quanterix Simoa® experts
- GLP/CLIA/ISO 15189 best practices compliance
CLIA-Licensed laboratory powered by ultra-sensitive Simoa® HD-X and SP-X technologies
Quantify proteins far lower than the Level of Quantification (LoQ) of conventional analog immunoassays
The largest portfolio of Simoa® instruments enables flexible scaling to handle studies of one plate up to thousands of samples
Full quality-management system infrastructure for end-to-end project management
Sample testing for longitudinal and prospective clinical studies
Custom assay development with the expertise of Quanterix Simoa® scientists
Laboratory performance according to applicable GLP/CLIA/ISO 15189 best practices
Exploratory biomarker analysis for enhanced PD studies
Quantify proteins that are BLOQ in typical immunoassay platforms and access baseline analytes in healthy subjects and disease indicators
Use your proprietary antibodies/reagents or commercially available reagents
The Accelerator Lab is built upon solid Simoa® foundations. This digital immunoassay technology has revolutionized biomarker detection by giving researchers the ability to examine critical proteins at ultra-low, femtogram levels. The Simoa® digital health solution is enabling early disease detection and approaches to treatment.Learn More About Our Simoa® Technology
A State-of-the-Art Facility Run by World Class Scientists
Our CLIA-licensed lab powers groundbreaking Simoa® technology and helps achieve research objectives all over the globe.
Quanterix’s team of dedicated scientists offer a depth of instrument experience and a breadth of knowledge on ultrasensitive assay development. Use their expertise to get instant access to Simoa® technology and personal guidance through the manufacturing process.
For more information on assay development timelines, download our brochure.
The Simoa® Accelerator Lab in Action
Learn more about how Disarm Therapeutics and the Quanterix Accelerator Lab are powering biomarker testing for axonal degeneration.
“The Accelerator Lab, and Quanterix in particular,
are the pioneers in this ultra-sensitive technology
to measure not only neurofilament
but other biomarkers. ”